Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / BIOTECH ETF
-
Total 13F shares
-
556,456
-
Share change
-
-19,756
-
Total reported value
-
$71,747,073
-
Put/Call ratio
-
8.6%
-
Price per share
-
$128.94
-
Number of holders
-
79
-
Value change
-
-$2,511,142
-
Number of buys
-
14
-
Number of sells
-
41
Institutional Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q2 2019
As of 30 Jun 2019,
VANECK ETF TRUST - BIOTECH ETF (BBH) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
556,456 shares.
The largest 10 holders included
UBS Group AG, MORGAN STANLEY, ROYAL BANK OF CANADA, CITADEL ADVISORS LLC, MURPHY CAPITAL MANAGEMENT INC, BANK OF AMERICA CORP /DE/, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MOGY JOEL R INVESTMENT COUNSEL INC, BOSTON RESEARCH & MANAGEMENT INC, and Strategic Financial Services, Inc,.
This page lists
79
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.